RS51112B - Farmaceutske kompozicije koje sadrže zd6474 - Google Patents
Farmaceutske kompozicije koje sadrže zd6474Info
- Publication number
- RS51112B RS51112B RSP-2009/0458A RSP20090458A RS51112B RS 51112 B RS51112 B RS 51112B RS P20090458 A RSP20090458 A RS P20090458A RS 51112 B RS51112 B RS 51112B
- Authority
- RS
- Serbia
- Prior art keywords
- pharmaceutical compositions
- diluent
- compressibility
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Farmaceutska kompozicija, naznačena time, da obuhvata ZD6474 ili njegovu farmaceutski prihvatljivu so, krhki razredivač i drugi razredivač koji je praktički p nerastvoriv u vodi i poseduje karakteristike rastegljivosti kompresije.Prijava sadrži još 4 patentna zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0411378.3A GB0411378D0 (en) | 2004-05-21 | 2004-05-21 | Pharmaceutical compositions |
| PCT/GB2005/001931 WO2005112934A1 (en) | 2004-05-21 | 2005-05-18 | Pharmaceutical compositions comprising zd6474 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51112B true RS51112B (sr) | 2010-10-31 |
Family
ID=32607743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2009/0458A RS51112B (sr) | 2004-05-21 | 2005-05-18 | Farmaceutske kompozicije koje sadrže zd6474 |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US8067427B2 (sr) |
| EP (1) | EP1753431B1 (sr) |
| JP (1) | JP4740947B2 (sr) |
| KR (1) | KR101192935B1 (sr) |
| CN (1) | CN101031303B (sr) |
| AR (2) | AR049059A1 (sr) |
| AT (1) | ATE439841T1 (sr) |
| AU (1) | AU2005244650B2 (sr) |
| BR (1) | BRPI0511253B8 (sr) |
| CA (1) | CA2565513C (sr) |
| CY (1) | CY1109500T1 (sr) |
| DE (1) | DE602005016105D1 (sr) |
| DK (1) | DK1753431T3 (sr) |
| ES (1) | ES2330025T3 (sr) |
| GB (1) | GB0411378D0 (sr) |
| HK (1) | HK1099220A1 (sr) |
| HR (1) | HRP20090547T1 (sr) |
| IL (1) | IL178928A (sr) |
| ME (2) | ME02778B (sr) |
| MX (1) | MXPA06013501A (sr) |
| MY (1) | MY138868A (sr) |
| NO (1) | NO338324B1 (sr) |
| NZ (1) | NZ550931A (sr) |
| PL (1) | PL1753431T3 (sr) |
| PT (1) | PT1753431E (sr) |
| RS (1) | RS51112B (sr) |
| RU (1) | RU2383343C2 (sr) |
| SA (1) | SA05260133B1 (sr) |
| SI (1) | SI1753431T1 (sr) |
| TW (1) | TWI355269B (sr) |
| UA (1) | UA81732C2 (sr) |
| UY (1) | UY28901A1 (sr) |
| WO (1) | WO2005112934A1 (sr) |
| ZA (1) | ZA200609110B (sr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2278511B1 (es) * | 2005-07-28 | 2008-06-16 | Laboratorios Almirall S.A. | Comprimidos con perfil de disolucion mejorado. |
| EP3039424B1 (en) | 2013-08-28 | 2020-07-29 | Crown Bioscience, Inc. (Taicang) | Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| IL149034A0 (en) * | 1999-11-05 | 2002-11-10 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| KR100419555B1 (ko) * | 2000-05-29 | 2004-02-19 | 주식회사유한양행 | 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자 |
| JP4542783B2 (ja) | 2002-03-05 | 2010-09-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有複素環化合物及び血管新生抑制剤とを組み合わせてなる抗腫瘍剤 |
-
2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
-
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh active
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en active Application Filing
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-18 EP EP05744858A patent/EP1753431B1/en active Active
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko active IP Right Grant
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh active Active
- 2005-05-18 CA CA2565513A patent/CA2565513C/en active Active
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de active Active
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja active Active
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es active Active
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
-
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
-
2007
- 2007-06-13 HK HK07106372.8A patent/HK1099220A1/xx unknown
-
2009
- 2009-10-13 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
-
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
| TW200621268A (en) | Antimicrobial copolymers and uses thereof | |
| HRP20020158B1 (en) | Action of synergistic combination | |
| RS53141B (sr) | Dvoslojna tableta koja sadrži telmisartan i amlodipin | |
| HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
| RS51569B (sr) | Kompozicije koje sadrže kristalni trans-(+/-)-delta-9-tetrahidrokanabinol | |
| HRP20020090B1 (hr) | FARMACEUTSKI PRIPRAVCI S Ăź-KARBOLINOM | |
| RS50407B (sr) | Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika | |
| IL182086A0 (en) | Compositions for use against one or more pathogens | |
| NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
| RS52315B (sr) | Derivati diarilmetil piperazina, njihova priprema i njihova upotreba | |
| DE60140997D1 (de) | Therapeutische zusammensetzungen zur pulmonalen verabreichung | |
| RS51112B (sr) | Farmaceutske kompozicije koje sadrže zd6474 | |
| HUP0400976A2 (hu) | VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
| BRPI0417265A (pt) | composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna | |
| RS51081B (sr) | Nova sinergistička kombinacija koja uključuje roflumilast i formoterol | |
| MXPA05009947A (es) | Composiciones limpiadoras en la forma de una tableta. | |
| DE60111503D1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
| HRP20020159B1 (en) | Multi-dose erythropoietin formulations | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| WO2006026172A3 (en) | Use of soluble cd26 as inhibitor of angiogenesis and inflammation | |
| TW200621304A (en) | Pharmaceutical composition | |
| RS50975B (sr) | Kompozicije koje obuhvataju molekularno dispergovani drospirenon | |
| WO2004111088A3 (en) | Angiogenic factor and inhibitors thereof |